A Perspective from the ‘Reimagining Psychedelic Trials’ Working Group Post published:February 2, 2023 Post category:2022 Year in Review
Historical Insights on the Psychedelic Renaissance Post published:February 2, 2023 Post category:2022 Year in Review
A Spotlight on Psychedelic Research Methods Post published:February 2, 2023 Post category:2022 Year in Review
Panel: Psychedelic Research Methods Post published:February 2, 2023 Post category:2022 Year in Review
The Agenda for Economic Analyses of Psychedelic-assisted Therapy Post published:February 1, 2023 Post category:2022 Year in Review
A Perspective on Providers: Scaling PAT in a Time of Therapist Shortages Post published:February 1, 2023 Post category:2022 Year in Review
Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy Post published:February 1, 2023 Post category:2022 Year in Review
Psychedelic Therapies: From Approvals to Access Post published:February 1, 2023 Post category:2022 Year in Review
Kabir Nath: Our Mission, Progress and Future Perspectives Post published:January 31, 2023 Post category:2022 Year in Review
Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs Post published:January 30, 2023 Post category:2022 Year in Review